New hepatitis b drug enters first human tests
Disease control
Recruiting now
This early-stage trial is testing an experimental drug called GIGA-2339 in 48 adults with chronic hepatitis B. The main goal is to check if the drug is safe and how the body processes it. Participants will receive either GIGA-2339 or a placebo by IV infusion, and researchers will…
Phase: PHASE1 • Sponsor: GigaGen, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC